97 related articles for article (PubMed ID: 4278576)
1. [Role of blood vessels in the pathogenesis of diffuse scleroderma].
Kamiński A
Przegl Dermatol; 1974; 61(5):639-47. PubMed ID: 4278576
[No Abstract] [Full Text] [Related]
2. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.
LeRoy EC; Black C; Fleischmajer R; Jablonska S; Krieg T; Medsger TA; Rowell N; Wollheim F
J Rheumatol; 1988 Feb; 15(2):202-5. PubMed ID: 3361530
[No Abstract] [Full Text] [Related]
3. [Various aspects of the pathogenesis of systemic scleroderma and the role of microcirculation in the morphogenesis of joint changes in the diseases].
Rusakova MS
Vopr Revm; 1982; (2):68-71. PubMed ID: 7113091
[No Abstract] [Full Text] [Related]
4. [Histochemistry of intra-organic vessels in diabetes mellitus].
Bodnar PN
Vrach Delo; 1971 Aug; 8():78. PubMed ID: 4259044
[No Abstract] [Full Text] [Related]
5. [Clinical evaluation of the determination of blood serum and urinary glycosaminoglycans in systemic scleroderma].
Fuzaĭlov OR; Astakhova TA; Guseva NG
Ter Arkh; 1984; 56(5):45-9. PubMed ID: 6463886
[No Abstract] [Full Text] [Related]
6. [Acid mucopolysaccharides in diffuse scleroderma].
Ishikawa H
Nihon Hifuka Gakkai Zasshi; 1972 Sep; 82(9):645-52. PubMed ID: 4265651
[No Abstract] [Full Text] [Related]
7. [Scleroderma--a vascular disease].
Keplan D
Ter Arkh; 1978; 50(9):102-4. PubMed ID: 705638
[No Abstract] [Full Text] [Related]
8. Evidence of microvascular injury in scleroderma and systemic lupus erythematosus: quantitative study of the microvascular bed.
Norton WL; Hurd ER; Lewis DC; Ziff M
J Lab Clin Med; 1968 Jun; 71(6):919-33. PubMed ID: 5654777
[No Abstract] [Full Text] [Related]
9. The connective tissue in scleroderma.
LeRoy EC
Coll Relat Res; 1981 Apr; 1(3):301-8. PubMed ID: 6286231
[No Abstract] [Full Text] [Related]
10. Scleroderma: pathogenic factors and current management.
Penny R
Aust N Z J Med; 1978; 8 Suppl 1():143-8. PubMed ID: 365159
[TBL] [Abstract][Full Text] [Related]
11. [Role of tryptophan metabolism in the pathogenesis of systemic scleroderma and pseudosclerodermic conditions].
Stachow A
Przegl Dermatol; 1979; 66(6):727-9. PubMed ID: 534291
[No Abstract] [Full Text] [Related]
12. The pathophysiology of the fibrosis in scleroderma skin.
Fleischmajer R; Perlish JS
Prog Clin Biol Res; 1984; 154():381-404. PubMed ID: 6382305
[No Abstract] [Full Text] [Related]
13. Pathogenesis of progressive systemic sclerosis.
Haustein UF; Herrmann K; Böhme HJ
Int J Dermatol; 1986 Jun; 25(5):286-93. PubMed ID: 3522447
[No Abstract] [Full Text] [Related]
14. Pathogenesis of scleroderma (systemic sclerosis).
LeRoy EC
J Invest Dermatol; 1982 Jul; 79 Suppl 1():87s-89s. PubMed ID: 7086194
[TBL] [Abstract][Full Text] [Related]
15. D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects.
Shapiro LS; Prince RK; Buckingham RB; Rodnan GP
J Rheumatol; 1983 Apr; 10(2):316-8. PubMed ID: 6864687
[TBL] [Abstract][Full Text] [Related]
16. [Vascular pathology in collagen diseases].
Hosoda Y
Saishin Igaku; 1969 Oct; 24(10):2060-81. PubMed ID: 4390726
[No Abstract] [Full Text] [Related]
17. Probable role of interleukin-1 in the pathogenesis of scleroderma.
Alarcón-Segovia D; Alcocer-Varela J
Arthritis Rheum; 1985 Nov; 28(11):1316-7. PubMed ID: 3877511
[No Abstract] [Full Text] [Related]
18. [Some possible mechanisms in pathogenesis of systemic scleroderma].
Lebedev DA
Ter Arkh; 1977; 49(11):126-30. PubMed ID: 605394
[No Abstract] [Full Text] [Related]
19. [Dynamics of the mucopolysaccharide components in the evolution of generalized scleroderma].
Bologa EI; Lucan G; Rugea P
G Ital Dermatol Minerva Dermatol; 1968; 109(6):485-92. PubMed ID: 4247023
[No Abstract] [Full Text] [Related]
20. [Serum and urinary glycosaminoglycans in various forms of scleroderma].
Kniazev IuA; Khamaganova IV
Revmatologiia (Mosk); 1986; (3):42-3. PubMed ID: 3538299
[No Abstract] [Full Text] [Related]
[Next] [New Search]
